Jesper Lau, PhD

Vice President, Digital Science & Innovation at Novo Nordisk A/S

Speaker

After his Ph.D. in organic chemistry in 1990 at University of Southern Denmark and stay in the group of Professor Barry Trost at Standford University in California, he joined Health Care Discovery at Novo Nordisk. Jesper Lau has 34 years’ experience in pharmaceutical discovery and holds a broad knowledge in small molecule-based therapeutics as well as a comprehensive know-how within protein engineering especially within metabolic disorders with particular interest in glucagon like peptide 1 (GLP-1). Since 2003 he was project manager for Novo Nordisk research project “once weekly GLP-1” and is inventor of semaglutide. He was appointed adjunct professor at Fudan University in Shanghai in 2016 and in addition to project management Jesper Lau has been line manager since 1995 and was in 2008 appointed vice president of Research Chemistry located in Denmark. In 2020 Jesper became vice of our US organization Chemical Biology in Indianapolis and Seattle and is now part of Digital Science and Innovation located in Denmark.